Abstract
INTRODUCTION: Prevalence of diabetes in Malaysia has increased over past decade, from 11.6% to 17.5%, which incur additional cost of MYR4.5 to 7.7 million annually. Generally, glycaemic control (HbA1c) of ?6.5% is recommended. In US, 34.1% T2DM patients with HbA1c level ?7%. Non-adherence to treatment ranging from 7-64% worldwide causing diabetes difficult to manage. Kedah has the highest prevalence of diabetes in Malaysia based on findings from NHMS 2015. This study aimed to examine the glycaemic control and management of patients with type-2 diabetes mellitus (T2DM) across all the 58 public health clinics in Kedah, Malaysia. METHODOLOGY: This is a cross sectional study whereby, the data was obtained from the National Diabetes Registry, with patients selected using stratified random sampling. RESULTS: Of the 23,577 patients followed up at the clinics during August 2016 and July 2017, only 15.6% had a glycosylated haemoglobin (HbA1C) level <6.5%. Meanwhile, 28.6% of them did not have their HbA1C levels tested over the 12-month period. While retinopathy appeared as the most prevalent diabetes-related complication (12.6%), combination treatment (?2 antidiabetic medications) was not used in nearly 30% of the patients with a HbA1C of 7.5-10.0%. Insulin therapy was also only given to 60.5% of those with a HbA1C>10.0%. DISCUSSION: Overall, the current management of T2DM patients at the primary care level in Kedah has been inadequate and warrants a revision.
Links
BibTeX (Download)
@proceedings{APCPH-2019-57,
title = {Glycaemic Control and Management of Type 2 Diabetes Patients Across Public Health Clinics in Kedah},
author = {Sharifah Saffinas Syed Soffian},
year = {2019},
date = {2019-07-22},
urldate = {2019-07-22},
journal = {6th Asia-Pacific Conference on Public Health 2019 Proceedings},
issue = {6},
abstract = {INTRODUCTION: Prevalence of diabetes in Malaysia has increased over past decade, from 11.6% to 17.5%, which incur additional cost of MYR4.5 to 7.7 million annually. Generally, glycaemic control (HbA1c) of ?6.5% is recommended. In US, 34.1% T2DM patients with HbA1c level ?7%. Non-adherence to treatment ranging from 7-64% worldwide causing diabetes difficult to manage. Kedah has the highest prevalence of diabetes in Malaysia based on findings from NHMS 2015. This study aimed to examine the glycaemic control and management of patients with type-2 diabetes mellitus (T2DM) across all the 58 public health clinics in Kedah, Malaysia. METHODOLOGY: This is a cross sectional study whereby, the data was obtained from the National Diabetes Registry, with patients selected using stratified random sampling. RESULTS: Of the 23,577 patients followed up at the clinics during August 2016 and July 2017, only 15.6% had a glycosylated haemoglobin (HbA1C) level \<6.5%. Meanwhile, 28.6% of them did not have their HbA1C levels tested over the 12-month period. While retinopathy appeared as the most prevalent diabetes-related complication (12.6%), combination treatment (?2 antidiabetic medications) was not used in nearly 30% of the patients with a HbA1C of 7.5-10.0%. Insulin therapy was also only given to 60.5% of those with a HbA1C\>10.0%. DISCUSSION: Overall, the current management of T2DM patients at the primary care level in Kedah has been inadequate and warrants a revision.},
note = {Type: ORAL PRESENTATION; Organisation: Kedah State Health Department, Malaysia},
keywords = {Hypoglycaemic agents, insulin, Malaysia, primary health care, type 2 diabetes mellitus},
pubstate = {published},
tppubtype = {proceedings}
}